Doctor Francesco Melillo
San Raffaele Hospital, Milan (Italy)
Member of:
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
Impact on outcome of different etiologies, baseline degree and improvement of mitral regurgitation in patients with aortic stenosis who underwent transcatheter aortic valve replacement
Event: EACVI - Best of Imaging 2020
Topic: Valvular Heart Disease
Session: Live Abstract Presentations - Valvular Heart Diseases
Two-years outcome of patients with heart failure and severe left ventricular dysfunction treated with ivabradine and low doses of beta-blocker
Event: Heart Failure 2018
Topic: Pharmacotherapy
Session: Chronic Heart Failure – Treatment
One-year clinical outcome and predictors of adverse events after percutaneous coronary intervention in elderly patients
Event: ESC Congress 2017
Topic: CAD and comorbidities
Session: CAD and comorbidities
Real-world single tertiary-care multidisciplinary experience with dabigatran, apixaban, rivaroxaban and warfarin in patients with renal failure and concomitant NVAF.
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Stroke prevention
Clinical outcome of low-dose regimen of dabigatran, apixaban, rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation: a single tertiary care multidisciplinary experience.
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Stroke prevention
ESC 365 is supported by
